Monsanto Licenses ToolGen’s CRISPR Technology

05:48 EDT 22 Aug 2017 | CHEManager

Monsanto has signed a global licensing agreement with South Korean biotech ToolGen, gaining access to its CRISPR gene-editing technology. Financial terms were not disclosed. "This agreement further validates our platform and demonstrates the value that gene-editing will hold for the future of both agriculture and biotechnology," said Jongmoon Kim, ToolGen's CEO.

Original Article: Monsanto Licenses ToolGen’s CRISPR Technology


More From BioPortfolio on "Monsanto Licenses ToolGen’s CRISPR Technology"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...